Annotated Medicine and Device Lists


Omeprazole

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 14 CAPSULAS
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO No observations
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 02. AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 16.01. ANTIACIDOS Y OTROS MEDICAMENTOS ANTIULCEROSOS No observations
Guyana. Essential Medicines List. 2020-2021 Proton Pump Inhibitors No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.36 Proton Pump Inhibitors No observations
Bahamas. Drug Formulary 01. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 01.03.02 Proton Pump Inhibitors No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations
Guyana. Essential Medicines List. 2020-2021 Proton Pump Inhibitors No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 56:40 Miscellaneous Gastrointestinal Agents No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
BULBO LIOFILIZADO PARA INYECCION X 10 ML
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 56:40 Miscellaneous Gastrointestinal Agents No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.36 Proton Pump Inhibitors No observations
Belize. National Drug Formulary 17.01 Antacids and other antiulcer medicines No observations

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 02. AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 01.03.02 Proton Pump Inhibitors No observations

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 07.02. MEDICAMENTOS ANTIULCEROSOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines This medicine has the best evidence for effectiveness and safety.
Costa Rica. Caja Costarricense de Seguro Social. 2019 32. Agentes gastrointestinales, antiácidos y antagonistas del receptor H2 No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines This medicine has the best evidence for effectiveness and safety.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines This medicine has the best evidence for effectiveness and safety.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines This medicine has the best evidence for effectiveness and safety.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines This medicine has the best evidence for effectiveness and safety.

This medicine is present in:

List Section Observation
Suriname. NGK-C-011 17.1 Antacids and other anti-ulcer agents No observations

This medicine is present in:

List Section Observation
Suriname. NGK-C-011 17.1 Antacids and other anti-ulcer agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.36 Proton Pump Inhibitors No observations
Belize. National Drug Formulary 17.01 Antacids and other antiulcer medicines No observations

Information Resources: Omeprazole

Loading ...
Loading ...
Loading ...
No information available